Ferrochelatase is a therapeutic target for ocular neovascularization

Ocular neovascularization underlies major blinding eye diseases such as “wet” age‐related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory patient populations necessitate discovery of new therape...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EMBO Mol Med
Egile Nagusiak: Basavarajappa, Halesha D, Sulaiman, Rania S, Qi, Xiaoping, Shetty, Trupti, Sheik Pran Babu, Sardar, Sishtla, Kamakshi L, Lee, Bit, Quigley, Judith, Alkhairy, Sameerah, Briggs, Christian M, Gupta, Kamna, Tang, Buyun, Shadmand, Mehdi, Grant, Maria B, Boulton, Michael E, Seo, Seung‐Yong, Corson, Timothy W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452042/
https://ncbi.nlm.nih.gov/pubmed/28377496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606561
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak